BlackRock’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Sell |
427,440
-75,354
| -15% | -$21.1K | ﹤0.01% | 4725 |
|
|
2025
Q1 | $156K | Sell |
502,794
-1,443
| -0.3% | -$447 | ﹤0.01% | 4603 |
|
|
2024
Q4 | $378K | Sell |
504,237
-145
| -0% | -$109 | ﹤0.01% | 4436 |
|
|
2024
Q3 | $630K | Buy |
504,382
+2,357
| +0.5% | +$2.95K | ﹤0.01% | 4226 |
|
|
2024
Q2 | $628K | Buy |
502,025
+1,975
| +0.4% | +$2.47K | ﹤0.01% | 4235 |
|
|
2024
Q1 | $560K | Sell |
500,050
-1,780
| -0.4% | -$1.99K | ﹤0.01% | 4284 |
|
|
2023
Q4 | $667K | Sell |
501,830
-878
| -0.2% | -$1.17K | ﹤0.01% | 4282 |
|
|
2023
Q3 | $533K | Sell |
502,708
-3,801
| -0.8% | -$4.03K | ﹤0.01% | 4340 |
|
|
2023
Q2 | $562K | Buy |
506,509
+4,902
| +1% | +$5.44K | ﹤0.01% | 4368 |
|
|
2023
Q1 | $742K | Sell |
501,607
-37,524
| -7% | -$55.5K | ﹤0.01% | 4349 |
|
|
2022
Q4 | $1.36M | Sell |
539,131
-464
| -0.1% | -$1.17K | ﹤0.01% | 4223 |
|
|
2022
Q3 | $1.73M | Buy |
539,595
+37,953
| +8% | +$122K | ﹤0.01% | 4179 |
|
|
2022
Q2 | $2.81M | Buy |
501,642
+14,164
| +3% | +$79.5K | ﹤0.01% | 3999 |
|
|
2022
Q1 | $3.01M | Sell |
487,478
-2,968
| -0.6% | -$18.3K | ﹤0.01% | 4132 |
|
|
2021
Q4 | $4.38M | Sell |
490,446
-40,820
| -8% | -$365K | ﹤0.01% | 3986 |
|
|
2021
Q3 | $5.17M | Buy |
531,266
+13,328
| +3% | +$130K | ﹤0.01% | 3886 |
|
|
2021
Q2 | $4.27M | Sell |
517,938
-1,437,136
| -74% | -$11.9M | ﹤0.01% | 3875 |
|
|
2021
Q1 | $18.7M | Buy |
1,955,074
+33,404
| +2% | +$319K | ﹤0.01% | 3170 |
|
|
2020
Q4 | $17.9M | Buy |
1,921,670
+119,761
| +7% | +$1.11M | ﹤0.01% | 3000 |
|
|
2020
Q3 | $24.5M | Buy |
1,801,909
+119
| +0% | +$1.62K | ﹤0.01% | 2686 |
|
|
2020
Q2 | $34.9M | Buy |
+1,801,790
| New | +$34.9M | ﹤0.01% | 2431 |
|
|
2018
Q2 | – | Sell |
-1,299
| Closed | -$3K | – | 4960 |
|
|
2018
Q1 | $3K | Buy |
+1,299
| New | +$3K | ﹤0.01% | 4718 |
|